Company Filing History:
Years Active: 1993
Title: Brent L. Iverson: Innovator in Catalytic Molecules
Introduction
Brent L. Iverson is a prominent inventor based in San Diego, California. He has made significant contributions to the field of catalytic molecules, particularly through his innovative patent work. His research focuses on the development of antibody combining site catalysts that utilize polyvalent metal ions.
Latest Patents
Iverson holds a patent for "Polyvalent metal ion-containing antibody combining site catalysts." This patent describes a catalytic molecule that comprises a receptor molecule containing an antibody combining site. This site immunologically binds to a variety of polyvalent metal ion-containing coordination complexes. The coordination complex of a first immunoligand is kinetically inert, while the coordination complex of a second immunoligand is kinetically labile. The receptor molecule is designed to catalyze a reaction involving the second immunoligand. Additionally, the patent discusses immunogens, antigens, and methods for creating and utilizing these catalytic receptors. It also includes receptor molecules that can catalyze the hydrolysis of a predetermined peptide bond. Iverson has 1 patent to his name.
Career Highlights
Brent L. Iverson is affiliated with the Scripps Clinic and Research Foundation, where he continues to advance his research in the field of biochemistry and molecular biology. His work has garnered attention for its potential applications in various scientific and medical fields.
Collaborations
Iverson has collaborated with Richard A. Lerner, a fellow researcher known for his contributions to immunology and biochemistry. Their partnership has led to advancements in the understanding of catalytic molecules and their applications.
Conclusion
Brent L. Iverson is a notable inventor whose work in catalytic molecules has the potential to impact various scientific fields. His innovative patent and collaborations highlight his commitment to advancing research in biochemistry.